Results 61 to 70 of about 718 (128)

Update on therapeutic approaches for invasive fungal infections in adults

Therapeutic Advances in Infectious Disease
Invasive fungal infections are increasingly encountered with the expansion of iatrogenic immunosuppression, including not only solid organ and hematopoietic stem cell transplant recipients but also patients with malignancies or autoimmune diseases ...
Catherine-Audrey Boutin, Me-Linh Luong
doaj   +1 more source

Fosmanogepix, új antifungális szer a gomba infekciók terápiájában

Az invazív gomba infekciók növekvő prevalenciája komoly problémát jelent az egészségügy számára. Az antifungális terápia ellenére, az invazív mikózisok továbbra is magas mortalitási arányt mutatnak az immunhiányos betegek körében.
Kelemen, Dorottya
core  

New preparations in systemic fungal infections [PDF]

Introducere Infecțiile fungice sistemice (invazive) reprezintă o problemă medicală și de sănătate publică majoră în ultimele două decenii. S-a estimat că, la nivel global, 1-1,2 miliarde de persoane sunt afectate de fungi, cu aproximativ 1,5 milioane ...
Spînosu, Galina, Bacinschi, Nicolae, Catcov, Carolina   +2 more
core   +1 more source

Clinical impact of fluconazole-resistant Candida parapsilosis: a narrative review

Fluconazole resistance in Candida parapsilosis is an increasing global concern, with resistance rates varying widely and reaching up to 80% in some regions.
Bartalucci, Claudia, Vena, Antonio, Bassetti, Matteo, Giacobbe, Daniele Roberto   +3 more
core   +1 more source

Antifungal treatment strategies in intensive care unit patients

Background: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among critically ill patients. In the intensive care unit (ICU), invasive candidiasis (IC), invasive pulmonary aspergillosis (IPA), and Pneumocystis jirovecii ...
Mezzogori, Laura, Schiavoni, Riccardo, Bartalucci, Claudia, Vena, Antonio, Bassetti, Matteo, Giacobbe, Daniele Roberto   +5 more
core   +1 more source

Novel antifungal agents for treating endemic mycoses: hope on the horizon?

Purpose of review Current treatments for endemic mycoses are limited by toxicity, drug–drug interactions, the need for therapeutic drug monitoring, and suboptimal penetration to sequestered sites. At the same time,
Nathan C. Bahr, Alessandro C. Pasqualotto, George R. Thompson   +2 more
core   +1 more source

Pathogenesis and Triazole Resistance in Aspergillus fumigatus: A Narrative Review Across the Host Immune Spectrum and One Health Context

Infection and Drug Resistance
Tianfang Chen,1,2,* Yelu Yao,2,* Jianwu Chen,3,* Huoyang Lv,1,2 Peng Nan21The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Laboratory Medicine Center ...
Chen T, Yao Y, Chen J, Lv H, Nan P
doaj  

Fusarium solani Skin and Soft Tissue Infection in a Patient With Chronic Sclerosing Skin Graft-vs-Host Disease: A Case Report. [PDF]

Am J Case Rep
Parker NJ, Quilitz R, Hussain HI, Caracciolo J, Klinkova O.   +4 more
europepmc   +1 more source

Non-Candida fungal cholecystitis - an uncommon occurrence even in the right host. [PDF]

Eur J Clin Microbiol Infect Dis
Dumais MG, Czech MM, Hyder MA, Lee RR, Gea-Banacloche JC, Kanakry CG, Kim SA, Adhikari B, Surette MD, Zelazny AM, Seyedmousavi A, Cuellar-Rodriguez JM.   +11 more
europepmc   +1 more source

Invasive Fusariosis-Time to Break the Mold. [PDF]

Transpl Infect Dis
Kovac V, Hammond SP.
europepmc   +1 more source